These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29073761)

  • 1. Targeted Gene Repression Using Novel Bifunctional Molecules to Harness Endogenous Histone Deacetylation Activity.
    Butler KV; Chiarella AM; Jin J; Hathaway NA
    ACS Synth Biol; 2018 Jan; 7(1):38-45. PubMed ID: 29073761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers.
    Chiarella AM; Wang TA; Butler KV; Jin J; Hathaway NA
    J Vis Exp; 2018 Sep; (139):. PubMed ID: 30295665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene.
    Liu JC; Baker RE; Chow W; Sun CK; Elsholtz HP
    Mol Endocrinol; 2005 Jul; 19(7):1904-17. PubMed ID: 15731170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase.
    Yu J; Angelin-Duclos C; Greenwood J; Liao J; Calame K
    Mol Cell Biol; 2000 Apr; 20(7):2592-603. PubMed ID: 10713181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific targeting and constitutive association of histone deacetylase complexes during transcriptional repression.
    Li J; Lin Q; Wang W; Wade P; Wong J
    Genes Dev; 2002 Mar; 16(6):687-92. PubMed ID: 11914274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locus-specific histone deacetylation using a synthetic CRISPR-Cas9-based HDAC.
    Kwon DY; Zhao YT; Lamonica JM; Zhou Z
    Nat Commun; 2017 May; 8():15315. PubMed ID: 28497787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex.
    Rampalli S; Pavithra L; Bhatt A; Kundu TK; Chattopadhyay S
    Mol Cell Biol; 2005 Oct; 25(19):8415-29. PubMed ID: 16166625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of epigenetic and cell-type specific regulation of Hey target genes in ES cells and cardiomyocytes.
    Weber D; Heisig J; Kneitz S; Wolf E; Eilers M; Gessler M
    J Mol Cell Cardiol; 2015 Feb; 79():79-88. PubMed ID: 25446183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the mSin3A-histone deacetylase 1/2 corepressor complex with the mouse steroidogenic acute regulatory protein gene.
    Clem BF; Clark BJ
    Mol Endocrinol; 2006 Jan; 20(1):100-13. PubMed ID: 16109738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical screen for epigenetic barriers to single allele activation of Oct4.
    Headley KM; Kedziora KM; Alejo A; Lai EZ; Purvis JE; Hathaway NA
    Stem Cell Res; 2019 Jul; 38():101470. PubMed ID: 31170660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an epigenetic signature of early mouse liver regeneration that is disrupted by Zn-HDAC inhibition.
    Huang J; Schriefer AE; Yang W; Cliften PF; Rudnick DA
    Epigenetics; 2014 Nov; 9(11):1521-31. PubMed ID: 25482284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant dynamics of histone deacetylation at the thyrotropin-releasing hormone gene in resistance to thyroid hormone.
    Ishii S; Yamada M; Satoh T; Monden T; Hashimoto K; Shibusawa N; Onigata K; Morikawa A; Mori M
    Mol Endocrinol; 2004 Jul; 18(7):1708-20. PubMed ID: 15131262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nuclear-envelope protein and transcriptional repressor LAP2beta interacts with HDAC3 at the nuclear periphery, and induces histone H4 deacetylation.
    Somech R; Shaklai S; Geller O; Amariglio N; Simon AJ; Rechavi G; Gal-Yam EN
    J Cell Sci; 2005 Sep; 118(Pt 17):4017-25. PubMed ID: 16129885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis.
    Coward WR; Watts K; Feghali-Bostwick CA; Jenkins G; Pang L
    Mol Cell Biol; 2010 Jun; 30(12):2874-86. PubMed ID: 20404089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic histone acetylation/deacetylation with progesterone receptor-mediated transcription.
    Aoyagi S; Archer TK
    Mol Endocrinol; 2007 Apr; 21(4):843-56. PubMed ID: 17227884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of the mouse M-lysozyme gene involves both hindrance of enhancer factor binding to the methylated enhancer and histone deacetylation.
    Ammerpohl O; Schmitz A; Steinm ller L; Renkawitz R
    Nucleic Acids Res; 1998 Dec; 26(23):5256-60. PubMed ID: 9826746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC inhibition through valproic acid modulates the methylation profiles in human embryonic kidney cells.
    Ganai SA; Kalladi SM; Mahadevan V
    J Biomol Struct Dyn; 2015; 33(6):1185-97. PubMed ID: 25012937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological Histone Deacetylation Distinguishes Transcriptional Regulators.
    Rafehi H; Karagiannis TC; El-Osta A
    Curr Top Med Chem; 2017; 17(14):1611-1622. PubMed ID: 27823568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A feed-forward repression mechanism anchors the Sin3/histone deacetylase and N-CoR/SMRT corepressors on chromatin.
    Vermeulen M; Walter W; Le Guezennec X; Kim J; Edayathumangalam RS; Lasonder E; Luger K; Roeder RG; Logie C; Berger SL; Stunnenberg HG
    Mol Cell Biol; 2006 Jul; 26(14):5226-36. PubMed ID: 16809761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
    Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A
    Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.